Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding site.

Karin A van Schie Simone Kruithof Pauline A van Schouwenburg Anke Vennegoor Joep Killestein Gertjan Wolbink Theo Rispens

J Allergy Clin Immunol

Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands; Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address:

Published: March 2017

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaci.2016.09.014	DOI Listing

Publication Analysis

Top Keywords

neutralizing capacity

capacity monoclonal

monoclonal polyclonal

polyclonal anti-natalizumab

anti-natalizumab antibodies

antibodies immune

immune response

response antibody

antibody therapeutics

therapeutics preferentially

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!